Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Clinical trial NCT06836063 · COMPLETED
Trial details
- NCT number
- NCT06836063
- Sponsor
- Suven Life Sciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-02-23
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.